Publications in collaboration with researchers from Istituto Superiore di Sanità (86)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

2023

  1. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes

    Frontiers in Oncology, Vol. 13

2022

  1. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

    Frontiers in Oncology, Vol. 12

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Cytokine signatures of plasmodium vivax infection during pregnancy and delivery outcomes

    PLoS Neglected Tropical Diseases, Vol. 14, Núm. 5, pp. 1-17

  2. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

2019

  1. Epidemiology of rare cancers and inequalities in oncologic outcomes

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11

  2. Human biomonitoring as a tool for exposure assessment in industrially contaminated sites (Icss). lessons learned within the ics and health european network

    Epidemiologia e Prevenzione, Vol. 43, Núm. 4, pp. 249-259

  3. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80

  4. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66

  5. Treatment challenges in and outside a network setting: Head and neck cancers

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45

  6. Treatment challenges in and outside a network setting: Soft tissue sarcomas

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39

  7. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51

2018

  1. A conceptual framework for the collection of food products in a Total Diet Study

    Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment, Vol. 35, Núm. 2, pp. 171-190

  2. A review of exposure assessment methods for epidemiological studies of health effects related to industrially contaminated sites

    Epidemiologia e Prevenzione, Vol. 42, Núm. 5-6, pp. 21-36

  3. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

    European Journal of Cancer, Vol. 93, pp. 127-137

2017

  1. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039

  2. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  3. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  4. Naturally acquired binding-inhibitory antibodies to Plasmodium vivax duffy binding protein in pregnant women are associated with higher birth weight in a multicenter study

    Frontiers in Immunology, Vol. 8, Núm. FEB